(Q39370686)

22469032

11 September 2017

title

Sox2 targets cyclinE, p27 and survivin to regulate androgen-independent human prostate cancer cell proliferation and apoptosis (English)

1 reference

11 September 2017

0 references

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6495851&resulttype=core&format=json

14 May 2020

Dong Li

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6495851&resulttype=core&format=json

14 May 2020

author name string

F Lin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6495851&resulttype=core&format=json

14 May 2020

P Lin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6495851&resulttype=core&format=json

14 May 2020

D Zhao

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6495851&resulttype=core&format=json

14 May 2020

Y Chen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6495851&resulttype=core&format=json

14 May 2020

L Xiao

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6495851&resulttype=core&format=json

14 May 2020

H Chen

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6495851&resulttype=core&format=json

14 May 2020

B Zhao

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6495851&resulttype=core&format=json

14 May 2020

H Zou

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6495851&resulttype=core&format=json

14 May 2020

X Zheng

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6495851&resulttype=core&format=json

14 May 2020

X Yu

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6495851&resulttype=core&format=json

14 May 2020

publication date

2 April 2012

1 reference

11 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6495851&resulttype=core&format=json

14 May 2020

volume

45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6495851&resulttype=core&format=json

14 May 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6495851&resulttype=core&format=json

14 May 2020

page(s)

207-216

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6495851&resulttype=core&format=json

14 May 2020

cites work

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2012.00812.X

S100A4 accelerates tumorigenesis and invasion of human prostate cancer through the transcriptional regulation of matrix metalloproteinase 9

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2012.00812.X

The cDNA sequence and chromosomal location of the human SOX2 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2012.00812.X

Developmental-specific activity of the FGF-4 enhancer requires the synergistic action of Sox2 and Oct-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2012.00812.X

Vertebrate neurogenesis is counteracted by Sox1-3 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2012.00812.X

From head to toes: the multiple facets of Sox proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2012.00812.X

Pairing SOX off: with partners in the regulation of embryonic development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2012.00812.X

Complex humoral immune response against a benign tumor: frequent antibody response against specific antigens as diagnostic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2012.00812.X

Histopathologic evaluation of stepwise progression of pancreatic carcinoma with immunohistochemical analysis of gastric epithelial transcription factor SOX2: comparison of expression patterns between invasive components and cancerous or nonneoplasti

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2012.00812.X

An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2012.00812.X

SOX2 silencing in glioblastoma tumor-initiating cells causes stop of proliferation and loss of tumorigenicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2012.00812.X

SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2012.00812.X

Expression of pluripotent stem cell reprogramming factors by prostate tumor initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2012.00812.X

Serological identification of embryonic neural proteins as highly immunogenic tumor antigens in small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2012.00812.X

SOX2 is an oncogene activated by recurrent 3q26.3 amplifications in human lung squamous cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2012.00812.X

SOX2 promotes tumorigenesis and increases the anti-apoptotic property of human prostate cancer cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2012.00812.X

Correlation of CD133, OCT4, and SOX2 in rectal cancer and their association with distant recurrence after chemoradiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2012.00812.X

Functional evidence that the self-renewal gene NANOG regulates human tumor development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2012.00812.X

Survivin, versatile modulation of cell division and apoptosis in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2012.00812.X

Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2012.00812.X

Validating survivin as a cancer therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2012.00812.X

Survivin expression is associated with features of biologically aggressive prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2012.00812.X

Survivin gene silencing sensitizes prostate cancer cells to selenium growth inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2012.00812.X

Novel combination therapy against metastatic and androgen-independent prostate cancer by using gefitinib, tamoxifen and etoposide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2012.00812.X

Evidence that SOX2 overexpression is oncogenic in the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2012.00812.X

The molecular mechanism governing the oncogenic potential of SOX2 in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2012.00812.X

Identification and interpretation of epidermal growth factor and c-erbB-2 overexpression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2012.00812.X

G1 phase progression: cycling on cue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2012.00812.X

CDK inhibitors: cell cycle regulators and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2012.00812.X

Cyclin-dependent kinase inhibitors: novel anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2012.00812.X

Epidermal growth factor receptor (ErbB1) expression in prostate cancer progression: correlation with androgen independence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2012.00812.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2012.00812.X

Complex post-transcriptional regulation of EGF-receptor expression by EGF and TGF-alpha in human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2012.00812.X

EGFR ligand switch in late stage prostate cancer contributes to changes in cell signaling and bone remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2012.00812.X

Gefitinib-trastuzumab combination on hormone-refractory prostate cancer xenograft

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2012.00812.X

Expression of Sox2 in human ovarian epithelial carcinoma

21 January 2018

1 reference

12 December 2020

Roles of Sox factors in neural determination: conserved signaling in evolution?

1 reference

12 December 2020

Survivin apoptosis: an interloper between cell death and cell proliferation in cancer.

1 reference

12 December 2020

The EGF receptor-sox2-EGF receptor feedback loop positively regulates the self-renewal of neural precursor cells

1 reference

12 December 2020

10.1111/J.1365-2184.2012.00812.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6495851&resulttype=core&format=json

14 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6495851&resulttype=core&format=json

14 May 2020

22469032

1 reference